The Biopolitics of Chronic Fatigue Syndrome

Total Page:16

File Type:pdf, Size:1020Kb

The Biopolitics of Chronic Fatigue Syndrome The Biopolitics of Chronic Fatigue Syndrome Thesis submitted for the degree of Doctor of Philosophy at the University of Leicester by Nikos Karfakis School of Management University of Leicester March 2013 Abstract The Biopolitics of Chronic Fatigue Syndrome by Nikos Karfakis This thesis approaches Chronic Fatigue Syndrome (CFS) as a biopolitical problem, that is as a shifting scientific object which needs to be studied, classified and regulated. Assemblages of authorities, knowledges, and techniques make CFS subjects and shape their everyday conduct in an attempt to increase their supposed autonomy, wellbeing and health. CFS identities are, however, made not only through government, scientific and medical interventions but also by the patients themselves, a biosocial community that collaborates with scientists, educates itself about the intricacies of biomedicine, and contests psychiatric truth claims. CFS is a socio-medical disorder, an illness trapped between medicine, psychology and society, an illness that is open to debate, and therefore difficult to manage and standardise. CFS is, thus, more than a fixed and defined medical category; it is a performative and multiple category, it is a heterogeneous world. This thesis studies that performative complexity by assembling different pieces of empirical data that constitute its heterogeneity: medical and psychiatric journals and monographs, self-help books, CFS organisations’ magazines, newsletters and websites, illness narratives and social studies of CFS, CFS blogs, and qualitative interviews with diagnosed CFS patients and CFS activists. The thesis delineates different interventions by medicine, science, the state and the patients themselves and concludes that CFS remains elusive, only partially standardised, in an on- going battle between all the different actors that want to define it for their own situated interests. i Acknowledgements I would like to take the opportunity to thank all those people without whom I would not have been able to complete this study. First of all, I want to thank all the people diagnosed with CFS who participated in my research for their trust and support. Many thanks to my supervisors, Dimitris Papadopoulos and Simon Lilley, for their trust, encouragement, and intellectual stimulation. They did everything possible to guide me, boost my confidence, and always have had time for me. I am indebted to them. I also want to thank Steve Brown, who introduced me to CFS and advised me at an early stage of the study. Mnay thanks also to my mother, Eleftheria Karfaki, for her financial and emotional support. Thanks to George Kokkinidis for reading some chapters of my study and for the often long discussions we had on a variety of issues. Thanks also to Juan Espinosa for the equally diverse and long discussions that we had. I cannot but refer to the exciting and intellectually vibrant community at the School of Management, University of Leicester. I would also like to thank all my friends in Leicester and in Greece for their emotional support. Finally, I thank all the people who assisted me during this journey. ii Table of Contents Abstract i Acknowledgements ii Table of Contents iii List of Figure and Tables v Figures v Tables v Abbreviations vi Introduction 1 Chapter One: The Biopolitics of CFS 10 The Biopolitics of CFS 10 The Politics of Scientific Objectivity 22 The Multiplicity of Politics 27 Research Questions 30 Chapter Two: Researching CFS 32 Research Design 35 Primary Empirical Study 36 Collection of Data and Analysis 41 Chapter Three: Towards a Genealogy of Fatigue and CFS 48 Vapours and Nerves 49 Neurasthenia and Da Costa’s Syndrome 53 Immunology and Stress 64 Chapter Four: Making CFS Objectivity 74 CFS: A Heterogeneous Object 74 The Nosology and Diagnosis of CFS 86 CFS Patients’ Organisations 101 Chapter Five: Standardising Through Intervening 112 In Search of Energy 112 Clinical Trials 128 iii Fatigue’s Cerebralisation? 135 The ‘Discovery’ of the XMRV Virus 142 Chapter Six: The Work Regulation of CFS 154 CFS and Precarity 156 Labour-Power and Disability 174 Measuring Fatigue 176 Chapter Seven: Conclusion 187 The Emergence of Fatigue 187 From Fatigue to CFS 190 CFS as a Scientific Mystery 192 Standardising CFS, Optimising Energy 195 CFS as a Welfare Problem 202 Appendix 207 Table of Themes 207 Notes 209 Bibliography 215 iv List of Figure and Tables Figures 1. Mosso’s finger ergograph 57 2. Photograph of one of the many fatigue experiments conducted in the 63 Harvard Laboratory between 1927 and 1952 3. Cartoon by Trish Campbell of the Warwickshire Network for ME 92 4. Regional differences between CFS/ME patients and controls 138 Tables 1. Example of a daily activity schedule 107 2. Published studies related to XMRV virus between October 2009 to June 2011 107-108 3. Unfunded applications to the MRC between 2002 and 2008 123 v Abbreviations AfME Action for M.E. APT Adaptive Pacing Therapy ADHD Attention Deficit Hyperactivity Disorder APA American Psychiatric Association APA American Productivity Audit APT Adaptive Pacing Therapy ARF Acute Renal Failure ASCL Association of School and College Leaders AYME Association of Young People with ME BA Benefits Agency BACME British Association for Chronic Fatigue Syndrome BRAME Blue Ribbon for the Awareness of ME CAB Citizens Advice Bureau CAM Complementary and Alternative Medicine CBT Cognitive Behaviour Therapy CDC Centre for Disease Control and Prevention CEBV Chronic Epstein-Barr Virus CIS Checklist Individual Strength CFCCC Chronic Fatigue Syndrome, Fibromyalgia, and Chemical Sensitivity Coalition of Chicago CFS Chronic Fatigue Syndrome CFSAC CFS Advisory Committee CFSCC CFS Coordinating Committee CFIDS Chronic Fatigue & Immune Dysfunction Syndrome CNCC Clinical Network Coordinating Centre CNS Central Nervous System CLASP Carers of Leicestershire and Support Project CSSD Complex Somatic Symptom Disorder CT Computerised Tomography DDS Depressive Disorders Study DLA Disability Living Allowance DSC DSM Diagnostic and Statistical Manual of Mental Disorders DTCA Direct-to-Consumer Advertising DWP Department of Work and Pensions EDS Excessive Daytime Sleepiness EBM Evidence-Based Medicine EBT Evidence-Based Treatment EBV Epstein-Barr Virus EC European Commission EMEA European ME Alliance ES Excessive Sleepiness ESA Employment and Support Allowance ESME European Society for ME ES Employment Service ESR Erythrocyte Sedimentation Rate vi FDA Food and Drug Administration FMS Fibromyalgia Syndrome FSD Female Sexual Dysfunction FSS Functional Somatic Syndromes GET Graded Exercise Therapy GP General Practitioner GWI Gulf War Illness HB Housing Benefit HE Healthy Eating HFME Hummingbird’s Foundation for M.E. HLA Human Leukocyte Antigen IACFS/ME International Association for Chronic Fatigue Syndrome/M.E. IB Incapacity Benefit ICD International Classification of Diseases IiME Invest in M.E. IS Income Support ISS Insufficient Sleep Syndrome LP Lightning Process LPT Lost Productive Time LSLY Low Sugar Low Yeast JCP JobCentre Plus JSA Job Seeker’s Allowance MBPS Munchausen’s by Proxy Syndrome MCL Mantle Cell Lymphoma ME Myalgic Encephalomyelitis MEA M.E. Association MES Medically Unexplained Symptoms MEG Magnetoencephalography MEG Monitoring and Evaluating Group MFMT Multifunctional Multitargeted MRC Medical Research Council MRI Magnetic Resonance Image NDA New Drug Application NDDP New Deal for Disabled People NEID Neuroendocrineimmune Deficiency Syndrome NI National Isurance NICE National Institute for Health and Clinical Excellence NIH National Institute of Health NIRS Near-Infrared Spectroscopy NHS National Health Service NLP Neuro-linguistic Programming NMEC National M.E. Centre NOW Netherlands Organization for Scientific Research NSAID Nonsteroidal Anti-Inflammatory Drug MCS Multiple Chemical Sensitivity MCS Maastrich Cohort Study ME Myalgic Encephalomyelitis MLV Murine Leukemia Virus MS Multiple Sclerosis MSC Manpower Services Commission vii PACE Pacing, Graded Activity and Cognitive Behaviour Therapy: A Randomised Evaluation PANDORA Patient Alliance for Neuroendocrineimmune Disorders Organization for Research and Advocacy, Inc. PI Principal Investigator PLDS Post Lyme Disease Syndrome PMS Premenstrual Syndrome PTSD Post-Traumatic Stress Disorder PVFS Post-Viral Fatigue Syndrome SAHS Sleep Apnea-Hypopnea Syndrome SMC Science Media Centre SMC Specialist Medical Care SNS Sympathetic Nervous System SSAC Social Security Advisory Committee RCT Randomised Clinical Trial UBO Unidentified Bright Object WBC White Blood Cells WHO World Health Organization WLQ Work Limitations Questionnaire WPI Whitemore Peterson Institute XMRV Xenotropic Murine Leukemia Virus-Related Virus viii Introduction After having been removed by force from her house and spent two years in a psychiatric hospital, 32-year-old Sophia Mirza was found dead on 25th November 2005.1 Sophia was affected by chronic fatigue syndrome (CFS), also known in the UK as myalgic encephalomyelitis (ME). CFS is a debilitating condition with a range of fluctuating symptoms which in its extreme manifestation constitutes patients bedridden. Scientists have for many years struggled to find its cause with no success. Some have suggested that there are physiological causes and in particular viral infections, and others that it is a psychological illness, a view that seems dominant. According to the account of Sophia’s mother, she had been told by her daughter’s general practitioner (GP) that Sophia had made herself ill and that she was keeping her ill as long as she was
Recommended publications
  • Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness
    This PDF is available from The National Academies Press at http://www.nap.edu/catalog.php?record_id=19012 Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness ISBN Committee on the Diagnostic Criteria for Myalgic 978-0-309-31689-7 Encephalomyelitis/Chronic Fatigue Syndrome; Board on the Health of Select Populations; Institute of Medicine 330 pages 6 x 9 PAPERBACK (2015) Visit the National Academies Press online and register for... Instant access to free PDF downloads of titles from the NATIONAL ACADEMY OF SCIENCES NATIONAL ACADEMY OF ENGINEERING INSTITUTE OF MEDICINE NATIONAL RESEARCH COUNCIL 10% off print titles Custom notification of new releases in your field of interest Special offers and discounts Distribution, posting, or copying of this PDF is strictly prohibited without written permission of the National Academies Press. Unless otherwise indicated, all materials in this PDF are copyrighted by the National Academy of Sciences. Request reprint permission for this book Copyright © National Academy of Sciences. All rights reserved. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness Beyond Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Redefining an Illness Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Board on the Health of Select Populations PREPUBLICATION COPY—Uncorrected Proofs Copyright © National Academy of Sciences. All rights reserved. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness THE NATIONAL ACADEMIES PRESS 500 Fifth Street, NW Washington, DC 20001 NOTICE: The project that is the subject of this report was approved by the Govern- ing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineer- ing, and the Institute of Medicine.
    [Show full text]
  • Advances in Me/Cfs Research and Clinical Care
    ADVANCES IN ME/CFS RESEARCH AND CLINICAL CARE EDITED BY : Kenneth J. Friedman, Lucinda Bateman, Alison Bested and Zaher Nahle PUBLISHED IN : Frontiers in Pediatrics and Frontiers in Neurology Frontiers eBook Copyright Statement About Frontiers The copyright in the text of individual articles in this eBook is the Frontiers is more than just an open-access publisher of scholarly articles: it is a property of their respective authors or their respective institutions or pioneering approach to the world of academia, radically improving the way scholarly funders. The copyright in graphics research is managed. The grand vision of Frontiers is a world where all people have and images within each article may be subject to copyright of other an equal opportunity to seek, share and generate knowledge. Frontiers provides parties. In both cases this is subject immediate and permanent online open access to all its publications, but this alone to a license granted to Frontiers. is not enough to realize our grand goals. The compilation of articles constituting this eBook is the property of Frontiers. Frontiers Journal Series Each article within this eBook, and the eBook itself, are published under The Frontiers Journal Series is a multi-tier and interdisciplinary set of open-access, the most recent version of the Creative Commons CC-BY licence. online journals, promising a paradigm shift from the current review, selection and The version current at the date of dissemination processes in academic publishing. All Frontiers journals are driven publication of this eBook is CC-BY 4.0. If the CC-BY licence is by researchers for researchers; therefore, they constitute a service to the scholarly updated, the licence granted by community.
    [Show full text]
  • Sensationalism Versus Science?
    Sensationalism versus Science? Malcolm Hooper and Margaret Williams 5th May 2013 The long-promised article by Michael Hanlon on the “war” surrounding the neuroimmune disorder myalgic encephalomyelitis (ME) was published today in the Sunday Times Magazine together with a photograph of Professor Sir Simon Wessely (“This man faced death threats and abuse. His crime? He suggested that ME was a mental illness”). Whilst the article focuses on the unacceptable actions of very few alleged sufferers and not on legitimate challenges mounted by scientists, it may be of interest to reproduce the questions which Hanlon sent to Professor Malcolm Hooper on 31st January and also Professor Hooper’s reply, since that reply provides the backdrop to the on-going “war”. First, though, it must be said that much of Hanlon’s article is factually wrong. For example, Hanlon begins his article with the assertion that “Professor Sir Simon Wessely lives on the front line of science”,which immediately reveals a lack of understanding in that Sir Simon does not live on the front line of biomedical science but on the front line of psychiatry, a discipline with no biomarkers of disease. Indeed Sir Simon ignores, actively denies or dismisses the evidence of biomedical scientists that demonstrates whole-body inflammation in ME and does not accept that it has now been shown to be an autoimmune disease. Hanlon goes on to state that Sir Simon “has done a lot of work for the military, helping to treat traumatised war veterans”, when there is irrefutable published evidence that Sir Simon has for decades denied the very existence of Gulf War Syndrome.
    [Show full text]
  • New ME Briefing 21 J
    1 Briefing for ‘Myalgic Encephalomyelitis: Treatment st and Research’ Westminster Hall, 21 ​ June 2018 ​ Contents About ME 3 ​ The Debate 3 Education of health professionals 4 Review of the NICE guideline on ME/CFS 5 NHS services 6 Children and young people with ME 7 Severe ME 7 Biomedical research 8 PACE trial 10 ME and welfare benefits 10 Social Care 11 References 13 Contact details 15 Appendix: The PACE Trial Controversy 16 This briefing has been produced jointly by #MEAction, Action for M.E., ME ​ ​ ​ ​ ​ Association and the ME Trust (for contact details, see page 15) ​ ​ ​ ​ ​ Supported by: Blue Ribbon for Awareness of ME, Centre for Welfare Reform, ​ ​ ​ ​ ​ Forward-ME, ME Research UK, WAMES ​ ​ ​ ​ 2 A bout ME Myalgic Encephalomyelitis (ME) is a chronic, fluctuating, neurological condition that causes symptoms affecting many body systems, more commonly the nervous and immune systems. ME affects an estimated 250,000 adults and children in the UK, and around 17 million people worldwide. People with ME experience severe, persistent fatigue associated with post-exertional malaise (PEM), their systems’ inability to recover after expending even small amounts of energy, leading to a flare-up in symptoms. PEM means that simple mental or physical activities can leave people with ​ ​ ME debilitated, experiencing a range of symptoms that are not significantly relieved by resting. PEM is the hallmark symptom of ME, other symptoms can include muscle and joint pain, cognitive difficulties, noise and light sensitivities and digestive problems. People with ME can vary enormously in their experience of the illness, and how their symptoms fluctuate. An estimated one in four children and adults with ME experience these symptoms severely (see ‘Severe ME’ on page 7).
    [Show full text]
  • Chronic Fatigue Syndrome/Myalgic
    # 13 – October 2015 1. Colofon / Personalia Scientific reviews: Richard Podell Advisory board: Leonard A. Jason Cartoons: Djanko Editor/Editorial team: David Egan, Eddy Keuninckx, Rob Wijbenga Textual contributions for the December-issue: Prof. Alan Light John Allsop Annet Lindhout Prof. Leonard Jason Bente Stenfalk Lieke Kops Brenda Vreeswijk Lisa Forstenius Dr. Byron Hyde Maartje Slot Carin Widholm Merry S. CJ Arlotta Michael Evison David Egan Dr. Neil Abbott Eddy Keuninckx P.E. Griffith Erica Verrillo Rebecca Hansen Faith Wong Dr. Richard Podell Greg & Linda Crowhurst Rob Wijbenga Helle Rasmussen Rosemary Underhill Jeannette Burmeister Ryan Prior Jerrold Spinhirne Sally K. Burch Jeryldine Saville Scott Jordan Harris Jo Best Staffan Christensen Joan McParland Distribution: Eddy Keuninckx Layout: Eddy Keuninckx Archive: http://let-me.be (here you can download all magazines for free) Facebook: https://www.facebook.com/groups/TheMEGlobalChronicle/ The editorial team doesn't accept any responsibility for any possible incorrect information that it has been supplied with and which has been published in this monthly issue. Anyone can subscribe to this free magazine by sending their email address to: [email protected] You can un-subscribe by sending a mail to: [email protected] Textual contributions for the October issue need to be supplied in Word by 10st December and sent to: [email protected] The next issue will come out on December 20nd,2015. Subscribe to this newsletter We are no association or society, just a bunch of idealists who want to give our best efforts towards recognition of this terrible disease. By trying to help connecting to each other all patients all over the world.
    [Show full text]
  • Straight-Jacketed by Empty Air
    Straight-jacketed by empty air Psychiatry’s long and shameful involvement in Myalgic Encephalomyelitis St Straight-jacketed by empty air Greg Crowhurst Please note that the publisher and the author cannot be held accountable for any damages or actions arising from reading this book, which is presented for informational purposes only. It is not intended as a substitute for professional medical advice. The views of contributors are not necessarily those of the publisher or author, under no circumstances can they be held accountable for any loss or claim arising out of the opinions expressed or suggestions made. “There is no doubt that ME is an organic disorder. The sufferers are denied proper recognition, misdiagnosed, vilified, ridiculed and driven to great depths of despair.” Hansard (House of Commons) 23rd February 188/columns 167-168 Books by Greg Crowhurst : Kevin Mayhew : St Pauls : Holy Way , Stonebird S Stonebird Holy Way Dedication I dedicate this, with all the love in my heart to my wife Linda, whose agony is beyond imagination or comprehension. All I have to help are these arms to reach out, hold and comfort, but that is more and more unbearable for her to cope with, so severe is her torture. Acknowledgements: Many, many thanks for all the support and enthusiasm for this book, it spurred me on! Special thanks to Rachel Higginson, Susanna Agardy, Geoffrey Keith Brown, Sally K Burch, Colleen Steckel, Nancy Blake, Corina Duyn, Clare Norton, Naomi Whittingham and Theresa Brennan. “I must emphasise that the most important message
    [Show full text]
  • Read the Full Survey Report
    Evaluating a Proposed Name to Replace ‘ME/CFS’: A Community Survey Project Conducted by Lisa Petrison, Ph.D. Published by Paradigm Change (March 2015) Copyright 2015 www.paradigmchange.me 2 Table of Contents Executive Summary ...................................................................................................................................... 5 Part 1 – Results Overview .......................................................................................................................... 13 Part 2 - Implications ................................................................................................................................... 29 Part 3 – Survey Questions .......................................................................................................................... 49 Part 4 – Main Survey Results ..................................................................................................................... 66 Part 5 – ME vs. Non-ME Results ............................................................................................................... 110 Part 6 – US ME vs. Non-ME Results ......................................................................................................... 127 Part 7 – Related Illnesses Results ............................................................................................................ 161 Part 8 – US vs. Non-US Results ................................................................................................................. 181
    [Show full text]
  • Journal of Iime Volume 1 Issue 1 2
    JJJooouuurrrnnnaaalll ooofff IIIiiiMMMEEE IIInnnvvveeesssttt iiinnn MMMEEE IIInnnttteeerrrnnnaaatttiiiooonnnaaalll MMMEEE///CCCFFFSSS CCCooonnnfffeeerrreeennnccceee 222000000777 SSSpppeeeccciiiaaalll VOLUME 1 ISSUE 1 Invest in ME Charity Nr 1114035 www.investinme.org Journal of IiME Volume 1 Issue 1 2 Welcome from Invest in ME Welcome to the first Journal of Invest in ME – a combination of research, information, news, stories and other articles relating to myalgic encephalomyelitis (ME). Facts About ME This first version is also serving a dual purpose in that it is acting as a An estimated 250,000 component of the delegate’s conference pack for the 2nd Invest in ME International ME/CFS Conference 2007, held in Westminster, London, UK. people suffer from ME in the UK Invest in ME welcomes delegates, presenters and media from ten countries around the world to the conference – emphasising that ME recognises no international boundaries. The interest in the conference also demonstrates the need for some of IiME’s main objectives – more education and proper funding for biomedical research into ME. In this document we include articles from renowned ME experts who ME Story were not able to be present at the conference this year as well as those who are. We also include other ME experts who are presenting. IiME I fell ill with the flu the hope to publish our journal throughout the year. As with the IiME same time as Antony, conference it will allow a platform for researchers, scientists, healthcare my then staff and politicians to be able to share and provide information boyfriend/fiancé. He relevant to those supporting, campaigning for or suffering from ME.
    [Show full text]
  • Parliamentary-Briefi
    1 Briefing for ‘Myalgic Encephalomyelitis: Treatment and Research’ Westminster Hall, 21st June 2018 Contents About ME 3 The Debate 3 Education of health professionals 4 Review of the NICE guideline on ME/CFS 5 NHS services 6 Children and young people with ME 7 Severe ME 7 Biomedical research 8 PACE trial 10 ME and welfare benefits 10 Social Care 11 References 13 Contact details 15 Appendix: The PACE Trial Controversy 16 This briefing has been produced jointly by #MEAction, Action for M.E., ME Association and the ME Trust (for contact details, see page 15) Supported by: Blue Ribbon for Awareness of ME, Centre for Welfare Reform, Forward-ME, ME Research UK, WAMES, Hope 4 ME & Fibro Northern Ireland 2 About ME Myalgic Encephalomyelitis (ME) is a chronic, fluctuating, neurological condition that causes symptoms affecting many body systems, more commonly the nervous and immune systems. ME affects an estimated 250,000 adults and children in the UK, and around 17 million people worldwide. People with ME experience severe, persistent fatigue associated with post-exertional malaise (PEM), their systems’ inability to recover after expending even small amounts of energy, leading to a flare-up in symptoms. PEM means that simple mental or physical activities can leave people with ME debilitated, experiencing a range of symptoms that are not significantly relieved by resting. PEM is the hallmark symptom of ME, other symptoms can include muscle and joint pain, cognitive difficulties, noise and light sensitivities and digestive problems. People with ME can vary enormously in their experience of the illness, and how their symptoms fluctuate.
    [Show full text]
  • Parliamentary Briefing
    1 BRIEFING FOR MYALGIC ENCEPHALOMYELITIS: 'TREATMENT AND RESEARCH' WESTMINSTER HALL, 21 JUNE 2018. (This briefing has been reproduced without amendment for the Back Bench Business debate on 24 Jan 2019) Contents About ME 3 Education of health professionals 4 Review of the NICE guideline on ME/CFS 5 NHS services 6 Children and young people with ME 7 Severe ME 7 Biomedical research 8 PACE trial 10 ME and welfare benefits 10 Social Care 11 References 13 Contact details 15 Appendix: The PACE Trial Controversy 16 This briefing has been produced jointly by #MEAction, Action for M.E., ME Association and the ME Trust (for contact details, see page 15) Supported by: Blue Ribbon for Awareness of ME, Centre for Welfare Reform, Forward-ME, ME Research UK, Tymes Trust, WAMES, Hope 4 ME & Fibro Northern Ireland, 25% M.E. Group 2 About ME Myalgic Encephalomyelitis (ME) is a chronic, fluctuating, neurological condition that causes symptoms affecting many body systems, more commonly the nervous and immune systems. ME affects an estimated 250,000 adults and children in the UK, and around 17 million people worldwide. People with ME experience severe, persistent fatigue associated with post-exertional malaise (PEM), their systems’ inability to recover after expending even small amounts of energy, leading to a flare-up in symptoms. PEM means that simple mental or physical activities can leave people with ME debilitated, experiencing a range of symptoms that are not significantly relieved by resting. PEM is the hallmark symptom of ME, other symptoms can include muscle and joint pain, cognitive difficulties, noise and light sensitivities and digestive problems.
    [Show full text]
  • CBT and GET Database
    www.hfme.org/cbtandget.htm A CBT and GET database CBT and GET database Copyright © Jodi Bassett September 2006. This version updated April 2009. Taken from www.hfme.org The CBT and GET Database is a stand-alone comprehensive guide to the use of CBT and GET on patients with Myalgic Encephalomyelitis (M.E.) and the bogus psychiatric or 'behavioural' paradigm of M.E. generally. This 170 + page resource is aimed at lawyers, politicians, media, the friends and family of sufferers - but primarily at those clinicians who choose to recommend CBT and GET to their patients. It is hoped that these doctors will read something here that will forever change their minds on this subject and so benefit their patients, and themselves, as well as society in general. TABLE OF CONTENTS: Page 3 Section 1: Introduction/Overview: Features the ‗Smoke and Mirrors‘ paper and includes a copy of ‗The effects of CBT and GET on patients with Myalgic Encephalomyelitis‘ Page 43 Section 2: Recommended background reading. Includes a copy of ‗A warning on ‗CFS,‘ ‗ICD- CFS‘ and ‗ME/CFS‘ research and advocacy‘ and ‗What is M.E.?‘ Page 69 Section 3: Research and articles which expose the lack of scientific legitimacy (and the hidden financial and political motivations) underlying the 'behavioural' paradigm of M.E. and the use of CBT and GET on M.E. patients Page 122 Section 4: A summary of the available medical research Page 132 Section 5: Patient accounts of CBT Page 153 Section 6: Patient accounts of GET Page 177 Section 7: Conclusion/Summary of key points (followed by a full reference list) www.hfme.org 2 A CBT and GET database Smoke and mirrors - An analysis of the scientific legitimacy of the claims that cognitive behavioural therapy (CBT) and graded exercise therapy (GET) are appropriate, safe and effective treatments for people with M.E.
    [Show full text]
  • Briefing for ‘Myalgic Encephalomyelitis: Treatment St and Research’ Westminster Hall, 21 ​ June 2018 ​
    1 Briefing for ‘Myalgic Encephalomyelitis: Treatment st and Research’ Westminster Hall, 21 ​ June 2018 ​ Contents About ME 3 ​ The Debate 3 Education of health professionals 4 Review of the NICE guideline on ME/CFS 5 NHS services 6 Children and young people with ME 7 Severe ME 7 Biomedical research 8 PACE trial 10 ME and welfare benefits 10 Social Care 11 References 13 Contact details 15 Appendix: The PACE Trial Controversy 16 This briefing has been produced jointly by #MEAction, Action for M.E., ME ​ ​ ​ ​ ​ Association and the ME Trust (for contact details, see page 15) ​ ​ ​ ​ ​ Supported by: Blue Ribbon for Awareness of ME, Centre for Welfare Reform, ​ ​ ​ ​ ​ Forward-ME, ME Research UK, WAMES, Hope 4 ME & Fibro Northern Ireland ​ ​ ​ ​ ​ ​ 2 A bout ME Myalgic Encephalomyelitis (ME) is a chronic, fluctuating, neurological condition that causes symptoms affecting many body systems, more commonly the nervous and immune systems. ME affects an estimated 250,000 adults and children in the UK, and around 17 million people worldwide. People with ME experience severe, persistent fatigue associated with post-exertional malaise (PEM), their systems’ inability to recover after expending even small amounts of energy, leading to a flare-up in symptoms. PEM means that simple mental or physical activities can leave people with ​ ​ ME debilitated, experiencing a range of symptoms that are not significantly relieved by resting. PEM is the hallmark symptom of ME, other symptoms can include muscle and joint pain, cognitive difficulties, noise and light sensitivities and digestive problems. People with ME can vary enormously in their experience of the illness, and how their symptoms fluctuate.
    [Show full text]